ÂÜÀòÂÒÂ×

David Ricketts is an experienced professional with over 25 years of work in the life science, pharmaceutical, and biotech industries. David has held roles such as Director of Business Development at Chemogenomix, Director of Business Development at MIP Diagnostics Limited, and Head of Business Development at GLAMOROUS.AI. Additionally, they have experience as a Partner at Discovery Business Development and as a CEO at Link Technologies Ltd. Most recently, David served as the Director of Business Development (CMO) at eTheRNA immunotherapies.

David Ricketts completed their Doctor of Philosophy (PhD) in Computational Chemistry from the University of Oxford from 1980 to 1986. Prior to that, they attended Sexeys from 1972 to 1980.